News

Kuros Biosciences grows sales to CHF 75.6 million for 2024

Schlieren (Zurich), Switzerland, March 11, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the full year 2024, marking another year of record growth, increased market penetration, and strategic portfolio advancements. Revenue from Direct MagnetOs...

read more

WuXi AppTec Seminar

Lunch & Learn with WuXi AppTec Come join us for an informative lunch event at the Superlab Zürich Schlieren! WuXi AppTec Experts will be sharing their expertise and insights to accelerate new drug discovery, so don’t miss out on this great opportunity to expand your knowledge. Lunch will be provided, so all...

read more